Canadian Pharmaceuticals & Biotech Strong Balance Sheet Stocks

Grown Rogue International

Market Cap: CA$154.7m

A craft cannabis company, focuses on premium flower and flower-derived products.

Trulieve Cannabis

Market Cap: CA$2.0b

Operates as a cannabis retailer.

Captor Capital

Market Cap: CA$1.6m

Engages in the retail sale of cannabis products in the United States.

Rubicon Organics

Market Cap: CA$41.0m

Engages in the production, processing, and sale of organic cannabis for the recreational and medical-use markets in Canada and internationally.

Avicanna

Market Cap: CA$29.5m

A commercial-stage biopharmaceutical company, engages in the research, development, advancement, and commercialization of evidence-based cannabinoid-based products and formulations for consumer, medical, and pharmaceutical markets in Canada and internationally.

InnoCan Pharma

Market Cap: CA$80.9m

A pharmaceutical technology company, focuses on the development of various drug delivery platforms combining cannabidiol (CBD) with other pharmaceutical ingredients in the United States, Canada, Europe, and internationally.

Auxly Cannabis Group

Market Cap: CA$202.3m

Operates as a consumer packaged goods company in the cannabis products market in Canada.

PharmaTher Holdings

Market Cap: CA$33.7m

A specialty pharmaceutical company, develops and commercialize specialty pharmaceuticals exhibiting the adoption and permitting novel delivery methods to enhance patient outcomes.

COSCIENS Biopharma

Market Cap: CA$10.8m

A life science company, develops and commercializes products for the cosmeceutical, nutraceutical and pharmaceutical markets in the United States, Germany, Colombia, the United Kingdom, and internationally.

Light AI

Market Cap: CA$22.9m

A healthcare technology company, focuses on developing artificial intelligence health diagnostic solutions designed to differentiate between bacterial and viral infections at point-of-care facilities.

Mountain Valley MD Holdings

Market Cap: CA$5.3m

A biotech company, focused on advancing solutions to optimize human, animal, and plant health in Canada.

Algernon Pharmaceuticals

Market Cap: CA$2.4m

Operates as a clinical stage pharmaceutical development company in Canada and Australia.

C21 Investments

Market Cap: CA$61.2m

An integrated cannabis company, cultivates, processes, distributes, and sells cannabis and hemp-derived consumer products in the United States.

Green Thumb Industries

Market Cap: CA$2.6b

Manufactures, distributes, markets, and sells of cannabis products for medical and adult-use in the United States.

Revive Therapeutics

Market Cap: CA$6.5m

A life sciences company, focuses on the research and development of therapeutics and diagnostics for infectious diseases, medical countermeasures, and rare disorders.

Sona Nanotech

Market Cap: CA$67.7m

Operates as a nanotechnology life sciences company.

Cytophage Technologies

Market Cap: CA$16.7m

A biotechnology company, engages in the research, development, and commercialization bacteriophage therapies to treat bacterial infections affecting human health, animal health, and food security in Canada.

RAMM Pharma

Market Cap: CA$1.8m

Engages in the pharmaceutical and medical product business in Uruguay, Italy, and Poland.

Medexus Pharmaceuticals

Market Cap: CA$96.6m

Operates as a pharmaceutical company in Canada and the United States.

Microbix Biosystems

Market Cap: CA$39.1m

A life science company, develops and commercializes proprietary biological and technological solutions for human health and wellbeing in North America, Europe, and internationally.

Knight Therapeutics

Market Cap: CA$604.9m

Focuses on acquiring, in-licensing, out-licensing, marketing, and commercializing prescription pharmaceutical products in Canada and Latin America.

Canopy Growth

Market Cap: CA$617.7m

Engages in the production, distribution, and sale of cannabis, hemp, and cannabis-related products in Canada, Germany, and Australia.

Telo Genomics

Market Cap: CA$7.5m

A molecular diagnostics company, engages in the development and commercialization of predictive technological products to personalize treatment plans for patients with specific conditions primarily in Canada.

Sharp Therapeutics

Market Cap: CA$15.0m

A preclinical-stage drug discovery company, develops therapeutics for genetic diseases.

Blueberries Medical

Market Cap: CA$7.4m

Engages in the growth, cultivation, and development of medicinal cannabis and related products in Colombia.

Christina Lake Cannabis

Market Cap: CA$9.9m

A license cannabis producer, engages in the research and development, cultivation, processing, production, and sale of cannabis in Canada.

Cardiol Therapeutics

Market Cap: CA$126.4m

A clinical-stage life sciences company, focuses on the developing of anti-fibrotic and anti-inflammatory therapies for the treatment of heart diseases.

Delivra Health Brands

Market Cap: CA$6.4m

Through its subsidiaries, provides lifestyle, health, and wellness products to consumers and patients worldwide.

BriaCell Therapeutics

Market Cap: CA$25.2m

A clinical stage immuno-oncology company, engages in developing targeted immunotherapies to transform cancer care.